Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Yu

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
The New England Journal of Medicine|December 14, 2016
Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant BCL11BDivya Punwani, Yong Zhang, Jason Yu, et al.
The Journal of Allergy and Clinical Immunology|August 13, 2021
Poor T-cell receptor β repertoire diversity early posttransplant for severe combined immunodeficiency predicts failure of immune reconstitutionOttavia M Delmonte, Riccardo Castagnoli, Jason Yu, et al.
Human Gene Therapy|September 10, 2016
Lentivirus Mediated Correction of Artemis-Deficient Severe Combined ImmunodeficiencyDivya Punwani, Misako Kawahara, Jason Yu, et al.
Oncogene|October 14, 2022
AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitorsShanade Dunn, Cath Eberlein, Jason Yu, et al.
The New England Journal of Medicine|December 22, 2022
Lentiviral Gene Therapy for Artemis-Deficient SCIDMorton J Cowan, Jason Yu, Janelle Facchino, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
The New England Journal of Medicine|December 14, 2016
Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant BCL11BDivya Punwani, Yong Zhang, Jason Yu, et al.
The Journal of Allergy and Clinical Immunology|August 13, 2021
Poor T-cell receptor β repertoire diversity early posttransplant for severe combined immunodeficiency predicts failure of immune reconstitutionOttavia M Delmonte, Riccardo Castagnoli, Jason Yu, et al.
Human Gene Therapy|September 10, 2016
Lentivirus Mediated Correction of Artemis-Deficient Severe Combined ImmunodeficiencyDivya Punwani, Misako Kawahara, Jason Yu, et al.
Oncogene|October 14, 2022
AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitorsShanade Dunn, Cath Eberlein, Jason Yu, et al.
The New England Journal of Medicine|December 22, 2022
Lentiviral Gene Therapy for Artemis-Deficient SCIDMorton J Cowan, Jason Yu, Janelle Facchino, et al.
Pageof 4